Needle Free Injectors Market Is Expected To Reach a Revenue Of USD 2,980.9 Million By 2033, At 8.1% CAGR: Dimension Market Research
11 nov. 2024 11h59 HE
|
Dimension Market Research
New York, Nov. 11, 2024 (GLOBE NEWSWIRE) -- Market Overview The Global Needle Free Injectors Market is projected to grow from USD 1,478.9 Million in 2024 to USD 2,980.9 Million by 2033, at a CAGR...
Unity Consortium Marks Adolescent Immunization Action Week (AIAW) with activities to help Parents and Adolescents get up to date on Recommended Vaccines
28 mars 2024 08h05 HE
|
Unity Consortium
Unity Consortium marks Adolescent Immunization Action Week, April 1-5, 2024, encouraging parents and adolescents to get up to date on recommended vaccines
New Video Series Arms Texas Educators and Health Professionals With Resources About Vaccine Efficacy
24 janv. 2024 07h00 HE
|
The Immunization Partnership
Houston, TX, Jan. 24, 2024 (GLOBE NEWSWIRE) -- The Immunization Partnership (TIP), a statewide nonprofit committed to a healthy Texas, is working to help Texas school and health officials educate...
Icosavax, Inc. Announces Agreement to be Acquired by AstraZeneca
12 déc. 2023 02h05 HE
|
Icosavax, Inc.
Icosavax, Inc. Announces Agreement to be Acquired by AstraZeneca
Icosavax Announces Positive Topline Interim Phase 2 Results for Combination VLP Vaccine Candidate IVX-A12 Against RSV and hMPV in Older Adults
12 déc. 2023 02h00 HE
|
Icosavax, Inc.
Icosavax Announces Positive Topline Interim Phase 2 Results for Combination VLP Vaccine Candidate IVX-A12 Against RSV and hMPV in Older Adults
Icosavax Reports Second Quarter 2023 Financial Results and Provides Corporate Update
14 août 2023 16h05 HE
|
Icosavax, Inc.
- Positive topline interim Phase 1 results for bivalent VLP vaccine candidate IVX-A12 against RSV and hMPV in older adults - - Positive twelve-month immunogenicity data and initial proof-of-concept...
Hypodermic Needles Market revenue to cross USD 9 Billion by 2035, says Research Nester
08 août 2023 07h00 HE
|
Research Nester
New York, Aug. 08, 2023 (GLOBE NEWSWIRE) -- The global hypodermic needles market size is projected to grow at a CAGR of over ~4% from 2023 to 2035. The market is expected to garner a revenue of USD...
Prevention and Immunization, the Key to Achieve a More Efficient Healthcare System Worldwide
03 juil. 2023 07h14 HE
|
Fundación Bamberg
BERLIN, July 03, 2023 (GLOBE NEWSWIRE) -- The Bamberg Foundation, together with key stakeholders from the healthcare and public sectors, gathered in Berlin to discuss the strategic priorities that...
AC Immune Receives FDA Fast Track Designation for Anti-Amyloid-beta Active Immunotherapy, ACI-24.060, to Treat Alzheimer’s Disease
27 juin 2023 07h00 HE
|
AC Immune SA
AC Immune Receives FDA Fast Track Designation for Anti-Amyloid-beta Active Immunotherapy, ACI-24.060, to Treat Alzheimer’s Disease Ongoing Phase 1b/2 ABATE study enrolling well and expanding to sites...
Dyadic Announces Expanded Licensing Agreement to Develop and Commercialize Vaccines and Biologics for African Continent
12 avr. 2023 08h00 HE
|
Dyadic International, Inc.
JUPITER, Fla., April 12, 2023 (GLOBE NEWSWIRE) -- Dyadic International, Inc. ("Dyadic", "we", "us", "our", or the "Company") (NASDAQ: DYAI), a global biotechnology company focused on building...